Alnylam Pharmaceuticals Inc (ALNY)
245.50
+6.63
(+2.78%)
USD |
NASDAQ |
Dec 20, 16:00
245.46
-0.04
(-0.02%)
After-Hours: 20:00
Alnylam Pharmaceuticals Profit Margin (Quarterly): -22.27% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| BridgeBio Pharma Inc | -5.93K% |
| Gilead Sciences Inc | 16.61% |
| Regeneron Pharmaceuticals Inc | 36.03% |
| Sarepta Therapeutics Inc | 7.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -8.43% |
| Return on Invested Capital | -36.66% |
| Gross Profit Margin (Quarterly) | 82.85% |
| Operating Margin (Quarterly) | -15.35% |
| Return on Net Operating Assets | -29.30% |